Kamada Ltd KMDA
News
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2026, Financial Results on November 9, 2026
Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
Sidoti Events, LLC's September Small-Cap Virtual Conference
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
